Abstract
This report is about a 62-year old male patient with an implantable cardioverter defibrillator (ICD) for patient activated termination of atrial fibrillation who experienced dofetilide-associated ventricular tachyarrhythmias and ICD-induced ventricular fibrillation six months after the initiation of the antiarrhythmic drug therapy.
MeSH terms
-
Anti-Arrhythmia Agents / adverse effects*
-
Atrial Fibrillation / therapy*
-
Defibrillators, Implantable / adverse effects*
-
Electrocardiography
-
Humans
-
Male
-
Middle Aged
-
Phenethylamines / adverse effects*
-
Sulfonamides / adverse effects*
-
Tachycardia, Ventricular / chemically induced*
-
Ventricular Fibrillation / etiology*
Substances
-
Anti-Arrhythmia Agents
-
Phenethylamines
-
Sulfonamides
-
dofetilide